Role of ghrelin in cognitive impairment of hypertensive elders with chronic psychological distress

Journal of Medical Colleges of PLA

Volumn 25, Issue 3, 2010, Pages 163-172

  Yushun, Zhang ^a,b   Fenling, Fan ^b   Hongyan, Tian ^b   Jun, Feng ^b   Xiancang, Ma ^b   Yamin, Liu ^b   Zhi, Hu ^b   Junbo, Zhang ^b   Yexin, Ma ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cognitive impairment; Elder; Ghrelin; Hypertension; Psychological stress

Indexed keywords

GHRELIN; HYDROCORTISONE;

AGED; AGING; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; CHRONIC DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PRIORITY JOURNAL; SCREENING TEST;

EID: 77955041189     PISSN: 10001948     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1000-1948(10)60035-4     Document Type: Article

References (29)

1. World Health Organization The World Health Report 2002: reducing risks, promoting healthy life 2002, World Health Organization, Geneva.
2. Ministry of Health, Ministry of Science and Technology, National Bureau of Statistics Report of a survey on Chinese residents nutrition and health, 2002[R] 2005, 1-25. People's Health Press, Beijing.
3. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
4. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
5. Fan FL, Zou YL, Ma AQ, et al. Hormonal changes and somatopsychologic manifestations in the first trimester of pregnancy and post partum. Int J Gynecol Obstetr 2009, 105:46-49.
6. Li XL, Mao JL Current study of essential hypertension and mental disorders. Adv Cardiovasc Dis 2007, 28(3):422-425.
7. Linden W, Moseley JV The efficacy of behavioral treatments for hypertension. Appl Psychophysiol Biofeedback 2006, 31:51-63.
8. Khan NA, Hemmelgarn B, Herman RJ, et al. Canadian Hypertension Education Program. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol 2008, 24:465-475.
9. Manoio TA, Olson J, Lon Gstreth T Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 2003, 5:255-261.
10. Hanon O, Pequignot R, Seux ML, et al. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. Hypertension 2006, 24:2101-2107.
11. Peila R, White LR, Masaki K, et al. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 2006, 37:1165-1170.
12. Kotani K, Sakane N, Saiga K, et al. Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome. Arch Med Res 2006, 37(7):903-906.
13. Kawczynska-Drozdz A, Olszanecki R, Jawien J, et al. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 2006, 19:764-767.
14. Bjorntorp P Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2001, 2:73-86.
15. Davies SJ, Ghahramani P, Jackson PR, et al. Association of panic disorder and panic attacks with hypertension. Am J Med 1999, 107:310-316.
16. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56(3):303-308.
17. He HB, Zhou HD, Chen ME, et al. Relationship between blood pressure and cognitive function of aged people in Chongqing communities stratified cluster sampling. Chin J Clin Rehab 2004, 8(24):5156-5157. (In Chinese).
18. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348(13):1215-1222.
19. Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 2000, 21(1):57-62.
20. Sabrina D, Susan AF, Stephen CB, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006, 9:381-388.
21. Carlini VP, Varas MM, Cragnolini AB, et al. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety like behavioral responses to ghrelin. Biochem Biophys Res Commun 2004, 313:635-641.
22. Roy GS, Lorena B, Yuxiang S Molecular endocrinology and physiology of the aging central nervous system. Endocrine Rev 2005, 26:203-250.
23. Rouach V, Blochb M, Rosenbergb N, et al. The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat. Psychoneuroendocrinology 2007, 32:693-702.
24. Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol 2001, 280:R1483-R1487.
25. Mary FD, Norman P, Susan FA, et al. Chronic stress and obesity: A new view of " comfort food" PNAS 2003, 100(20):11696-11701.
26. Tschop M, Weyer C, Tataranni A, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
27. Okumura H, Nagaya N, Enomoto M, et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002, 39:779-783.
28. Matsumura K, Tsuchihashi T, Fujii K, et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002, 40:694-699.
29. Bisi G, Podio V, Valetto MR, et al. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans. J Endocrinol Invest 1999, 22:266-272.